Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China · Delayed Price · Currency is CNY 19.37
+0.58 (3.09%)
Sep 14, 2026, 3:00 PM CST
SHA:688393 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 356.56 | 344.45 | 470.79 | 497.29 | 507.38 | 438.99 |
Revenue Growth | -11.33% | -26.84% | -5.33% | -1.99% | 15.58% | 16.93% |
Gross Profit Gross Profit Growth | 225.48 | 212.99 | 311.18 | 335.42 | 358.41 | 340.39 |
Operating Income Operating Income Growth | -44.75 | -66.45 | -4.56 | 7.54 | 21.49 | 58.8 |
Net Income Net Income Growth | -33.76 | -47.02 | 21.29 | 40.06 | 42.69 | 79.78 |
Earnings Per Share EPS Growth | -0.40 | -0.50 | 0.23 | 0.42 | 0.45 | 0.85 |
EPS Growth | - | - | -45.24% | -6.67% | -47.06% | -22.02% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
South China South China Growth | 84.87 |
East China East China Growth | 97.83 |
North China North China Growth | 47.46 |
Northwest China Northwest China Growth | 24.8 |
Central China Central China Growth | 35.85 |
Southwest China Southwest China Growth | 39.4 |
Northeast China Northeast China Growth | 5.65 |
Overseas Overseas Growth | 1.41 |
Total Total Growth | 337.27 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 287.48 | 265.63 | 150.48 | 120.25 | 266.45 | 637.1 |
Total Debt Total Debt Growth | 2.53 | 3.1 | 10.44 | 28.39 | 24.8 | 12.39 |
Net Cash (Debt) Net Cash Growth | 284.94 | 262.53 | 140.04 | 91.86 | 241.64 | 624.71 |
Net Cash Growth | 93.39% | 87.46% | 52.45% | -61.99% | -61.32% | -26.13% |
Net Cash Per Share Net Cash Per Share Growth | 3.38 | 2.79 | 1.51 | 0.96 | 2.55 | 6.66 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 24.3 | 40.02 | 3.54 | 17.12 | 9.72 | 59.61 |
Capital Expenditures CapEx Growth | -25.89 | -23.15 | -23.65 | -37.74 | -72.17 | -143.34 |
Free Cash Flow Free Cash Flow Growth | -1.59 | 16.87 | -20.1 | -20.62 | -62.45 | -83.73 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 63.24% | 61.84% | 66.10% | 67.45% | 70.64% | 77.54% |
Operating Margin | -12.55% | -19.29% | -0.97% | 1.52% | 4.23% | 13.39% |
Pretax Margin | -10.78% | -16.02% | 2.00% | 3.39% | 5.67% | 20.21% |
Profit Margin | -9.47% | -13.65% | 4.52% | 8.05% | 8.42% | 18.17% |
FCF Margin | -0.45% | 4.90% | -4.27% | -4.15% | -12.31% | -19.07% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.100 | 0.150 | 0.140 | 0.270 |
Dividend Per Share Growth | 0% | 0% | -33.33% | 7.14% | -48.15% | -3.57% |
Dividend Yield | 0.49% | 0.42% | 0.58% | 0.61% | 0.65% | 0.92% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 76.07 | 58.33 | 48.10 | 35.65 |
P/FCF Ratio | - | 131.43 | - | - | - | - |
PS Ratio | 5.08 | 6.44 | 3.44 | 4.70 | 4.05 | 6.48 |